References
- Munoz-Espin D, Serrano M. Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol 2014; 15:482-496; PMID: 24954210; http://dx.doi.org/10.1038/nrm3823
- Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguria A, Zaballos A, Flores JM, Barbacid M, et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436:642; PMID: 16079833; http://dx.doi.org/10.1038/436642a
- Pare R, Yang T, Shin JS, Lee CS. The significance of the senescence pathway in breast cancer progression. J Clin Pathol 2013; 66:491-495; PMID: 23539738; http://dx.doi.org/10.1136/jclinpath-2012-201081
- Kan CE, Cipriano R, Jackson MW. c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M. Cancer Res 2011; 71:6930-6939; PMID: 21975934; http://dx.doi.org/10.1158/0008-5472.CAN-10-3860
- Cipriano R, Kan CE, Graham J, Danielpour D, Stampfer M, Jackson MW. TGF-β signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells. Proc Natl Acad Sci USA 2011; 108:8668-8673; PMID: 21555587; http://dx.doi.org/10.1073/pnas.1015022108
- Bryson BL, Junk DJ, Cipriano R, Jackson MW. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced senescence. Cell Cycle 2016; 16(4):319-334; PMID: 27892764; http://dx.doi.org/10.1080/15384101.2016.1259037
- Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol 2014; 26:54-74; PMID: 24552665; http://dx.doi.org/10.1016/j.smim.2014.01.001